Table 1. Patient characteristics at enrolment into the treatment access program.
| Variable | Overall | Males | Females | P-Value |
|---|---|---|---|---|
| Overall | ||||
| Number enrolled | 395 | 134 | 261 | |
| Median age in years at screening (IQR) | 34.4 (29.3-39.8) | 36.9 (31.0-41.5) | 33.5 (27.9-38.3) | <.0001 |
| Median CD4 count at screening (IQR) | 22.0 (8.0-37.0) | 23.5 (9.0-38.0) | 20.0 (8.0-36.0) | 0.4192 |
| Median days to ARV initiation (IQR) | 7.0 (6.0-12.0) | 7.0 (6.0-11.0) | 7.0 (6.0-13.0) | 0.7335 |
| 2004-2007 | ||||
| Number enrolled | 262 | 86 | 176 | |
| Median age in years at screening (IQR) | 35.0 (29.7-40.3) | 36.7 (31.4-41.1) | 34.0 (28.2-39.4) | 0.0094 |
| Median CD4 count at screening (IQR) | 20.0 (8.0-36.0) | 19.5 (7.0-37.0) | 20.0 (8.0-35.5) | 0.9723 |
| Median days to ARV initiation (IQR) | 7.0 (6.0-11.0) | 6.0 (5.0-8.0) | 7.0 (6.0-13.0) | 0.0645 |
| 2008-2010 | ||||
| Number enrolled | 133 | 48 | 85 | |
| Median age in years at screening (IQR) | 33.5 (28.8-38.9) | 37.6 (31.0-43.7) | 32.4 (27.6-35.9) | 0.0016 |
| Median CD4 count at screening (IQR) | 23.0 (10.0-38.0) | 25.5 (11.5-40.0) | 22.0 (9.0-37.0) | 0.2203 |
| Median days to ARV initiation (IQR) | 7.0 (6.0-13.0) | 9.0 (7.0-17.5) | 7.0 (6.0-12.0) | 0.0743 |